Global Human Papillomavirus (HPV) Testing Market Insights, Forecast to 2031

Report ID: 1667088 | Published Date: Jan 2025 | No. of Page: 126 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Pap Smear Test
        1.2.3 HPV DNA Test
    1.3 Market by Application
        1.3.1 Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Diagnostic Centers
        1.3.3 Hospitals
        1.3.4 Clinic
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Human Papillomavirus (HPV) Testing Market Perspective (2017-2028)
    2.2 Human Papillomavirus (HPV) Testing Growth Trends by Region
        2.2.1 Human Papillomavirus (HPV) Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Human Papillomavirus (HPV) Testing Historic Market Size by Region (2017-2022)
        2.2.3 Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2023-2028)
    2.3 Human Papillomavirus (HPV) Testing Market Dynamics
        2.3.1 Human Papillomavirus (HPV) Testing Industry Trends
        2.3.2 Human Papillomavirus (HPV) Testing Market Drivers
        2.3.3 Human Papillomavirus (HPV) Testing Market Challenges
        2.3.4 Human Papillomavirus (HPV) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue
        3.1.1 Global Top Human Papillomavirus (HPV) Testing Players by Revenue (2017-2022)
        3.1.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Human Papillomavirus (HPV) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Human Papillomavirus (HPV) Testing Revenue
    3.4 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio
        3.4.1 Global Human Papillomavirus (HPV) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human Papillomavirus (HPV) Testing Revenue in 2021
    3.5 Human Papillomavirus (HPV) Testing Key Players Head office and Area Served
    3.6 Key Players Human Papillomavirus (HPV) Testing Product Solution and Service
    3.7 Date of Enter into Human Papillomavirus (HPV) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Human Papillomavirus (HPV) Testing Breakdown Data by Type
    4.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Type (2017-2022)
    4.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2023-2028)
5 Human Papillomavirus (HPV) Testing Breakdown Data by Application
    5.1 Global Human Papillomavirus (HPV) Testing Historic Market Size by Application (2017-2022)
    5.2 Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Human Papillomavirus (HPV) Testing Market Size (2017-2028)
    6.2 North America Human Papillomavirus (HPV) Testing Market Size by Type
        6.2.1 North America Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022)
        6.2.2 North America Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028)
        6.2.3 North America Human Papillomavirus (HPV) Testing Market Share by Type (2017-2028)
    6.3 North America Human Papillomavirus (HPV) Testing Market Size by Application
        6.3.1 North America Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022)
        6.3.2 North America Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028)
        6.3.3 North America Human Papillomavirus (HPV) Testing Market Share by Application (2017-2028)
    6.4 North America Human Papillomavirus (HPV) Testing Market Size by Country
        6.4.1 North America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
        6.4.2 North America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Human Papillomavirus (HPV) Testing Market Size (2017-2028)
    7.2 Europe Human Papillomavirus (HPV) Testing Market Size by Type
        7.2.1 Europe Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022)
        7.2.2 Europe Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028)
        7.2.3 Europe Human Papillomavirus (HPV) Testing Market Share by Type (2017-2028)
    7.3 Europe Human Papillomavirus (HPV) Testing Market Size by Application
        7.3.1 Europe Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022)
        7.3.2 Europe Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028)
        7.3.3 Europe Human Papillomavirus (HPV) Testing Market Share by Application (2017-2028)
    7.4 Europe Human Papillomavirus (HPV) Testing Market Size by Country
        7.4.1 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
        7.4.2 Europe Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (2017-2028)
    8.2 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Type
        8.2.1 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Human Papillomavirus (HPV) Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Application
        8.3.1 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Human Papillomavirus (HPV) Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region
        8.4.1 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Human Papillomavirus (HPV) Testing Market Size (2017-2028)
    9.2 Latin America Human Papillomavirus (HPV) Testing Market Size by Type
        9.2.1 Latin America Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Human Papillomavirus (HPV) Testing Market Share by Type (2017-2028)
    9.3 Latin America Human Papillomavirus (HPV) Testing Market Size by Application
        9.3.1 Latin America Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Human Papillomavirus (HPV) Testing Market Share by Application (2017-2028)
    9.4 Latin America Human Papillomavirus (HPV) Testing Market Size by Country
        9.4.1 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size (2017-2028)
    10.2 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Type
        10.2.1 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Human Papillomavirus (HPV) Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Application
        10.3.1 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Human Papillomavirus (HPV) Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country
        10.4.1 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Human Papillomavirus (HPV) Testing Introduction
        11.1.4 Roche Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Agilent Technologies
        11.2.1 Agilent Technologies Company Details
        11.2.2 Agilent Technologies Business Overview
        11.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Introduction
        11.2.4 Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.2.5 Agilent Technologies Recent Developments
    11.3 Becton, DickinsonandCompany
        11.3.1 Becton, DickinsonandCompany Company Details
        11.3.2 Becton, DickinsonandCompany Business Overview
        11.3.3 Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Introduction
        11.3.4 Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.3.5 Becton, DickinsonandCompany Recent Developments
    11.4 QiagenN.V.
        11.4.1 QiagenN.V. Company Details
        11.4.2 QiagenN.V. Business Overview
        11.4.3 QiagenN.V. Human Papillomavirus (HPV) Testing Introduction
        11.4.4 QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.4.5 QiagenN.V. Recent Developments
    11.5 Thermo FisherScientificInc.
        11.5.1 Thermo FisherScientificInc. Company Details
        11.5.2 Thermo FisherScientificInc. Business Overview
        11.5.3 Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Introduction
        11.5.4 Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.5.5 Thermo FisherScientificInc. Recent Developments
    11.6 Abbott Laboratories
        11.6.1 Abbott Laboratories Company Details
        11.6.2 Abbott Laboratories Business Overview
        11.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Introduction
        11.6.4 Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.6.5 Abbott Laboratories Recent Developments
    11.7 HologicInc.
        11.7.1 HologicInc. Company Details
        11.7.2 HologicInc. Business Overview
        11.7.3 HologicInc. Human Papillomavirus (HPV) Testing Introduction
        11.7.4 HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.7.5 HologicInc. Recent Developments
    11.8 CepheidInc.
        11.8.1 CepheidInc. Company Details
        11.8.2 CepheidInc. Business Overview
        11.8.3 CepheidInc. Human Papillomavirus (HPV) Testing Introduction
        11.8.4 CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.8.5 CepheidInc. Recent Developments
    11.9 SeegeneInc.
        11.9.1 SeegeneInc. Company Details
        11.9.2 SeegeneInc. Business Overview
        11.9.3 SeegeneInc. Human Papillomavirus (HPV) Testing Introduction
        11.9.4 SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.9.5 SeegeneInc. Recent Developments
    11.10 TakaraBio Inc.
        11.10.1 TakaraBio Inc. Company Details
        11.10.2 TakaraBio Inc. Business Overview
        11.10.3 TakaraBio Inc. Human Papillomavirus (HPV) Testing Introduction
        11.10.4 TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.10.5 TakaraBio Inc. Recent Developments
    11.11 DaAnGeneof SunYat-SenUniversity
        11.11.1 DaAnGeneof SunYat-SenUniversity Company Details
        11.11.2 DaAnGeneof SunYat-SenUniversity Business Overview
        11.11.3 DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Introduction
        11.11.4 DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.11.5 DaAnGeneof SunYat-SenUniversity Recent Developments
    11.12 PromegaCorporation
        11.12.1 PromegaCorporation Company Details
        11.12.2 PromegaCorporation Business Overview
        11.12.3 PromegaCorporation Human Papillomavirus (HPV) Testing Introduction
        11.12.4 PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.12.5 PromegaCorporation Recent Developments
    11.13 GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
        11.13.1 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Details
        11.13.2 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
        11.13.3 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Introduction
        11.13.4 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.13.5 GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Developments
    11.14 Enzo Biochem Inc.
        11.14.1 Enzo Biochem Inc. Company Details
        11.14.2 Enzo Biochem Inc. Business Overview
        11.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Introduction
        11.14.4 Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.14.5 Enzo Biochem Inc. Recent Developments
    11.15 NorgenBiotek
        11.15.1 NorgenBiotek Company Details
        11.15.2 NorgenBiotek Business Overview
        11.15.3 NorgenBiotek Human Papillomavirus (HPV) Testing Introduction
        11.15.4 NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.15.5 NorgenBiotek Recent Developments
    11.16 DiagCorBioscienceIncLtd
        11.16.1 DiagCorBioscienceIncLtd Company Details
        11.16.2 DiagCorBioscienceIncLtd Business Overview
        11.16.3 DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Introduction
        11.16.4 DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.16.5 DiagCorBioscienceIncLtd Recent Developments
    11.17 Hybribio Limited
        11.17.1 Hybribio Limited Company Details
        11.17.2 Hybribio Limited Business Overview
        11.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Introduction
        11.17.4 Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.17.5 Hybribio Limited Recent Developments
    11.18 ZytovisionGmbH
        11.18.1 ZytovisionGmbH Company Details
        11.18.2 ZytovisionGmbH Business Overview
        11.18.3 ZytovisionGmbH Human Papillomavirus (HPV) Testing Introduction
        11.18.4 ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.18.5 ZytovisionGmbH Recent Developments
    11.19 ArborVitaCorporation
        11.19.1 ArborVitaCorporation Company Details
        11.19.2 ArborVitaCorporation Business Overview
        11.19.3 ArborVitaCorporation Human Papillomavirus (HPV) Testing Introduction
        11.19.4 ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.19.5 ArborVitaCorporation Recent Developments
    11.20 Medical& BiologicalLaboratoriesCo., Ltd
        11.20.1 Medical& BiologicalLaboratoriesCo., Ltd Company Details
        11.20.2 Medical& BiologicalLaboratoriesCo., Ltd Business Overview
        11.20.3 Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Introduction
        11.20.4 Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.20.5 Medical& BiologicalLaboratoriesCo., Ltd Recent Developments
    11.21 Fujirebio Diagnostics
        11.21.1 Fujirebio Diagnostics Company Details
        11.21.2 Fujirebio Diagnostics Business Overview
        11.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Introduction
        11.21.4 Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022)
        11.21.5 Fujirebio Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Pap Smear Test
    Table 3. Key Players of HPV DNA Test
    Table 4. Global Human Papillomavirus (HPV) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Human Papillomavirus (HPV) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Human Papillomavirus (HPV) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Human Papillomavirus (HPV) Testing Market Share by Region (2017-2022)
    Table 8. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Human Papillomavirus (HPV) Testing Market Share by Region (2023-2028)
    Table 10. Human Papillomavirus (HPV) Testing Market Trends
    Table 11. Human Papillomavirus (HPV) Testing Market Drivers
    Table 12. Human Papillomavirus (HPV) Testing Market Challenges
    Table 13. Human Papillomavirus (HPV) Testing Market Restraints
    Table 14. Global Human Papillomavirus (HPV) Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Human Papillomavirus (HPV) Testing Revenue Share by Players (2017-2022)
    Table 16. Global Top Human Papillomavirus (HPV) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2021)
    Table 17. Ranking of Global Top Human Papillomavirus (HPV) Testing Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Human Papillomavirus (HPV) Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Human Papillomavirus (HPV) Testing Product Solution and Service
    Table 21. Date of Enter into Human Papillomavirus (HPV) Testing Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2017-2022)
    Table 25. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Human Papillomavirus (HPV) Testing Revenue Market Share by Type (2023-2028)
    Table 27. Global Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Human Papillomavirus (HPV) Testing Revenue Share by Application (2017-2022)
    Table 29. Global Human Papillomavirus (HPV) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Human Papillomavirus (HPV) Testing Revenue Share by Application (2023-2028)
    Table 31. North America Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Human Papillomavirus (HPV) Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Roche Company Details
    Table 62. Roche Business Overview
    Table 63. Roche Human Papillomavirus (HPV) Testing Product
    Table 64. Roche Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 65. Roche Recent Developments
    Table 66. Agilent Technologies Company Details
    Table 67. Agilent Technologies Business Overview
    Table 68. Agilent Technologies Human Papillomavirus (HPV) Testing Product
    Table 69. Agilent Technologies Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 70. Agilent Technologies Recent Developments
    Table 71. Becton, DickinsonandCompany Company Details
    Table 72. Becton, DickinsonandCompany Business Overview
    Table 73. Becton, DickinsonandCompany Human Papillomavirus (HPV) Testing Product
    Table 74. Becton, DickinsonandCompany Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 75. Becton, DickinsonandCompany Recent Developments
    Table 76. QiagenN.V. Company Details
    Table 77. QiagenN.V. Business Overview
    Table 78. QiagenN.V. Human Papillomavirus (HPV) Testing Product
    Table 79. QiagenN.V. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 80. QiagenN.V. Recent Developments
    Table 81. Thermo FisherScientificInc. Company Details
    Table 82. Thermo FisherScientificInc. Business Overview
    Table 83. Thermo FisherScientificInc. Human Papillomavirus (HPV) Testing Product
    Table 84. Thermo FisherScientificInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 85. Thermo FisherScientificInc. Recent Developments
    Table 86. Abbott Laboratories Company Details
    Table 87. Abbott Laboratories Business Overview
    Table 88. Abbott Laboratories Human Papillomavirus (HPV) Testing Product
    Table 89. Abbott Laboratories Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 90. Abbott Laboratories Recent Developments
    Table 91. HologicInc. Company Details
    Table 92. HologicInc. Business Overview
    Table 93. HologicInc. Human Papillomavirus (HPV) Testing Product
    Table 94. HologicInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 95. HologicInc. Recent Developments
    Table 96. CepheidInc. Company Details
    Table 97. CepheidInc. Business Overview
    Table 98. CepheidInc. Human Papillomavirus (HPV) Testing Product
    Table 99. CepheidInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 100. CepheidInc. Recent Developments
    Table 101. SeegeneInc. Company Details
    Table 102. SeegeneInc. Business Overview
    Table 103. SeegeneInc. Human Papillomavirus (HPV) Testing Product
    Table 104. SeegeneInc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 105. SeegeneInc. Recent Developments
    Table 106. TakaraBio Inc. Company Details
    Table 107. TakaraBio Inc. Business Overview
    Table 108. TakaraBio Inc. Human Papillomavirus (HPV) Testing Product
    Table 109. TakaraBio Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 110. TakaraBio Inc. Recent Developments
    Table 111. DaAnGeneof SunYat-SenUniversity Company Details
    Table 112. DaAnGeneof SunYat-SenUniversity Business Overview
    Table 113. DaAnGeneof SunYat-SenUniversity Human Papillomavirus (HPV) Testing Product
    Table 114. DaAnGeneof SunYat-SenUniversity Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 115. DaAnGeneof SunYat-SenUniversity Recent Developments
    Table 116. PromegaCorporation Company Details
    Table 117. PromegaCorporation Business Overview
    Table 118. PromegaCorporation Human Papillomavirus (HPV) Testing Product
    Table 119. PromegaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 120. PromegaCorporation Recent Developments
    Table 121. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Company Details
    Table 122. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Business Overview
    Table 123. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Human Papillomavirus (HPV) Testing Product
    Table 124. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 125. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Recent Developments
    Table 126. Enzo Biochem Inc. Company Details
    Table 127. Enzo Biochem Inc. Business Overview
    Table 128. Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Product
    Table 129. Enzo Biochem Inc. Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 130. Enzo Biochem Inc. Recent Developments
    Table 131. NorgenBiotek Company Details
    Table 132. NorgenBiotek Business Overview
    Table 133. NorgenBiotek Human Papillomavirus (HPV) Testing Product
    Table 134. NorgenBiotek Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 135. NorgenBiotek Recent Developments
    Table 136. DiagCorBioscienceIncLtd Company Details
    Table 137. DiagCorBioscienceIncLtd Business Overview
    Table 138. DiagCorBioscienceIncLtd Human Papillomavirus (HPV) Testing Product
    Table 139. DiagCorBioscienceIncLtd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 140. DiagCorBioscienceIncLtd Recent Developments
    Table 141. Hybribio Limited Company Details
    Table 142. Hybribio Limited Business Overview
    Table 143. Hybribio Limited Human Papillomavirus (HPV) Testing Product
    Table 144. Hybribio Limited Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 145. Hybribio Limited Recent Developments
    Table 146. ZytovisionGmbH Company Details
    Table 147. ZytovisionGmbH Business Overview
    Table 148. ZytovisionGmbH Human Papillomavirus (HPV) Testing Product
    Table 149. ZytovisionGmbH Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 150. ZytovisionGmbH Recent Developments
    Table 151. ArborVitaCorporation Company Details
    Table 152. ArborVitaCorporation Business Overview
    Table 153. ArborVitaCorporation Human Papillomavirus (HPV) Testing Product
    Table 154. ArborVitaCorporation Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 155. ArborVitaCorporation Recent Developments
    Table 156. Medical& BiologicalLaboratoriesCo., Ltd Company Details
    Table 157. Medical& BiologicalLaboratoriesCo., Ltd Business Overview
    Table 158. Medical& BiologicalLaboratoriesCo., Ltd Human Papillomavirus (HPV) Testing Product
    Table 159. Medical& BiologicalLaboratoriesCo., Ltd Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 160. Medical& BiologicalLaboratoriesCo., Ltd Recent Developments
    Table 161. Fujirebio Diagnostics Company Details
    Table 162. Fujirebio Diagnostics Business Overview
    Table 163. Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Product
    Table 164. Fujirebio Diagnostics Revenue in Human Papillomavirus (HPV) Testing Business (2017-2022) & (US$ Million)
    Table 165. Fujirebio Diagnostics Recent Developments
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Papillomavirus (HPV) Testing Market Share by Type: 2021 VS 2028
    Figure 2. Pap Smear Test Features
    Figure 3. HPV DNA Test Features
    Figure 4. Global Human Papillomavirus (HPV) Testing Market Share by Application: 2021 VS 2028
    Figure 5. Diagnostic Centers Case Studies
    Figure 6. Hospitals Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Human Papillomavirus (HPV) Testing Report Years Considered
    Figure 9. Global Human Papillomavirus (HPV) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Human Papillomavirus (HPV) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human Papillomavirus (HPV) Testing Market Share by Region: 2021 VS 2028
    Figure 12. Global Human Papillomavirus (HPV) Testing Market Share by Players in 2021
    Figure 13. Global Top Human Papillomavirus (HPV) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Testing as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Human Papillomavirus (HPV) Testing Revenue in 2021
    Figure 15. North America Human Papillomavirus (HPV) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Human Papillomavirus (HPV) Testing Market Size Market Share by Type (2017-2028)
    Figure 17. North America Human Papillomavirus (HPV) Testing Market Size Market Share by Application (2017-2028)
    Figure 18. North America Human Papillomavirus (HPV) Testing Market Size Share by Country (2017-2028)
    Figure 19. United States Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Human Papillomavirus (HPV) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Human Papillomavirus (HPV) Testing Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Human Papillomavirus (HPV) Testing Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Human Papillomavirus (HPV) Testing Market Size Share by Country (2017-2028)
    Figure 25. Germany Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Human Papillomavirus (HPV) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Human Papillomavirus (HPV) Testing Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Human Papillomavirus (HPV) Testing Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Human Papillomavirus (HPV) Testing Market Size Share by Region (2017-2028)
    Figure 35. China Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Human Papillomavirus (HPV) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Human Papillomavirus (HPV) Testing Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Human Papillomavirus (HPV) Testing Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Human Papillomavirus (HPV) Testing Market Size Share by Country (2017-2028)
    Figure 45. Mexico Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Human Papillomavirus (HPV) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Human Papillomavirus (HPV) Testing Market Size Share by Country (2017-2028)
    Figure 51. Turkey Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Human Papillomavirus (HPV) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Roche Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 55. Agilent Technologies Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 56. Becton, DickinsonandCompany Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 57. QiagenN.V. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 58. Thermo FisherScientificInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 59. Abbott Laboratories Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 60. HologicInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 61. CepheidInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 62. SeegeneInc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 63. TakaraBio Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 64. DaAnGeneof SunYat-SenUniversity Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 65. PromegaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 66. GreinerBio-OneInternationalGmbH(GreinerHoldingAG) Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 67. Enzo Biochem Inc. Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 68. NorgenBiotek Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 69. DiagCorBioscienceIncLtd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 70. Hybribio Limited Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 71. ZytovisionGmbH Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 72. ArborVitaCorporation Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 73. Medical& BiologicalLaboratoriesCo., Ltd Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 74. Fujirebio Diagnostics Revenue Growth Rate in Human Papillomavirus (HPV) Testing Business (2017-2022)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Agilent Technologies
Becton, DickinsonandCompany
QiagenN.V.
Thermo FisherScientificInc.
Abbott Laboratories
HologicInc.
CepheidInc.
SeegeneInc.
TakaraBio Inc.
DaAnGeneof SunYat-SenUniversity
PromegaCorporation
GreinerBio-OneInternationalGmbH(GreinerHoldingAG)
Enzo Biochem Inc.
NorgenBiotek
DiagCorBioscienceIncLtd
Hybribio Limited
ZytovisionGmbH
ArborVitaCorporation
Medical& BiologicalLaboratoriesCo., Ltd
Fujirebio Diagnostics
Frequently Asked Questions
Human Papillomavirus (HPV) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Papillomavirus (HPV) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Papillomavirus (HPV) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Human Vision Sensor

Human Vision Sensor market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More

Humanized Mice Model

Humanized Mice Model market is segmented by players, region (country), by Type and by Application ... Read More